Small Chloroquine Study Halted Over Risk of Fatal Heart Complications
A research trial of coronavirus patients in Brazil ended after patients taking a higher dose of chloroquine, one of the drugs President Trump has promoted, developed irregular heart rates.
Source: NYT Health - Category: Consumer Health News Authors: Katie Thomas and Knvul Sheikh Tags: Hydroxychloroquine (Drug) Azithromycin (Drug) Research Coronavirus (2019-nCoV) Drugs (Pharmaceuticals) Manaus (Brazil) Source Type: news
More News: American Health | Azithromycin | Brazil Health | Cardiology | Coronavirus | COVID-19 | Health | Heart | Hydroxychloroquine | Study | Trump | USA Health | Zithromax